NYSE · Medical - Instruments & Supplies

Becton, Dickinson and Company (BDX) Stock

$183.75 +0.55% NYSE: BDX Healthcare

Valuation

MetricValue
Price$183.75
Market Cap$50.63B
P/E Ratio55.37
P/B Ratio2.07
P/S Ratio2.43
EPS (TTM)$0.00
52-Week High$193.07
52-Week Low$127.59
Dividend Yield2.28%

Financials & Margins

MetricValue
ROE3.79%
ROA1.85%
ROCE4.96%
Gross Margin11.80%
Operating Margin11.80%
Net Margin4.52%
Debt/Equity0.69
Current Ratio1.11

Annual Financials (USD)

Metric20212022202320242025
Revenue$19.1B$18.9B$19.4B$20.2B$21.8B
Operating Profit$2.3B$2.3B$2.1B$2.4B$2.6B
Net Profit$2.1B$1.8B$1.5B$1.7B$1.7B
EPS$6.85$5.88$4.94$5.86$5.83
Op Margin11.8%12.1%10.9%11.9%11.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$53.9B$52.9B$52.8B$57.3B$55.3B
Total Liabilities$30.2B$27.7B$27.0B$31.4B$29.9B
Cash$2.4B$1.2B$1.4B$1.9B$851.0M
Borrowings$18.4B$17.0B$16.8B$21.6B$19.2B

Latest News

BD to Announce Financial Results for its Third Quarter of Fiscal 2026 PR Newswire · Jul 9, 2026 The Wide Chasm Priced Into Boston Scientific Stock Trefis · Jul 9, 2026 Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says MT Newswires · Jul 9, 2026 Becton Dickinson (BDX) Stock Trades At A Discount On Cash Flow And Earnings Simply Wall St. · Jul 9, 2026 Becton Dickinson (BDX) Joins New Russell Indexes, Is The Stock Below Fair Value? Simply Wall St. · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$4.6B$2.6B$3.0B$3.8B$3.4B
Investing Cash Flow$-3.1B$-4.2B$-1.6B$-6.2B$-1.6B
Financing Cash Flow$-2.0B$569.0M$-121.0M$-588.0M$-1.1B
Net Cash Flow$-525.0M$-1.2B$322.0M$375.0M$-1.0B
Free Cash Flow$3.4B$1.7B$2.1B$3.1B$2.7B

Valuation & Return Ratios

MetricValue
PEG Ratio-1.37
EV / EBITDA17.13
FCF Yield5.15%
Quick Ratio0.51
Interest Coverage3.77
Return 1Y26.71%
Return 3Y-6.98%
Return 5Y5.07%

Ownership

Insiders Held0.42%
Institutions Held99.01%
Institutions Float Held99.43%
Institutional HolderSharesReport Date
Blackrock Inc.26,153,4112026-03-31
Vanguard Capital Management LLC18,490,6102026-03-31
Vanguard Portfolio Management LLC15,317,2422026-03-31
State Street Corporation13,822,8082026-03-31
First Eagle Investment Management, LLC11,928,1112026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABTAbbott Laboratories $99.60 +1.13% 32.57 $172.35B 2.49%
BAXBaxter International Inc. $24.35 +1.88% -11.46 $12.59B 0.17%
BLFSBioLife Solutions, Inc. $38.61 +0.00% 36.07 $1.89B 0.00%
EMBCEmbecta Corp. $5.69 -1.13% 3.97 $337.28M 0.68%
ICUIICU Medical, Inc. $160.32 +2.00% 132.82 $4.01B 0.00%

About Becton, Dickinson and Company

Becton, Dickinson and Company is led by CEO Thomas E. Polen Jr., employs 70,000 people, headquartered in Franklin Lakes, US, publicly traded since 1973.

Becton, Dickinson and Company (BDX) stock trades at $183.75 with a market capitalization of $50.63B. The stock is valued at a price-to-earnings (P/E) ratio of 55.37, price-to-book of 2.07, price-to-sales of 2.43. Over the past 52 weeks the stock has ranged between $127.59 and $193.07, and currently trades 4.8% below its 52-week high. It pays a dividend yielding 2.28%.

On profitability, Becton, Dickinson and Company generates a return on equity (ROE) of 3.79%, return on capital employed of 4.96%, an operating margin of 11.80%, a net profit margin of 4.52%.

In its most recent fiscal year, Becton, Dickinson and Company reported annual revenue of $21.8B, net profit of $1.7B, revenue has compounded at 6.3% a year over the last five years, profit at 13.9% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.69, a current ratio of 1.11, total assets of $55.3B, $851.0M in cash and equivalents.

BDX has a beta of 0.26 (less volatile than the overall market).

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides